GOLDMAN SACHS GROUP INC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 271 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$14,139,832
-56.8%
1,693,393
-31.2%
0.00%
-57.1%
Q2 2023$32,742,486
+21.9%
2,461,841
+6.1%
0.01%
+16.7%
Q1 2023$26,857,402
+29.3%
2,319,292
-8.7%
0.01%
+20.0%
Q4 2022$20,778,517
-2.1%
2,540,161
-30.5%
0.01%0.0%
Q3 2022$21,220,000
-43.1%
3,655,445
-56.7%
0.01%
-37.5%
Q2 2022$37,299,000
+41.1%
8,438,572
+190.5%
0.01%
+33.3%
Q1 2022$26,432,000
-51.7%
2,904,619
+8.6%
0.01%
-45.5%
Q4 2021$54,744,000
-9.4%
2,675,655
+13.1%
0.01%
-15.4%
Q3 2021$60,443,000
-34.3%
2,365,677
-10.0%
0.01%
-38.1%
Q2 2021$91,931,000
+126.5%
2,628,842
+115.8%
0.02%
+110.0%
Q1 2021$40,581,000
+480.1%
1,218,288
+351.8%
0.01%
+400.0%
Q4 2020$6,995,000
+70.3%
269,644
-35.2%
0.00%
+100.0%
Q3 2020$4,108,000
+29.7%
416,263
-54.7%
0.00%0.0%
Q2 2020$3,168,000
-60.4%
918,241
-64.9%
0.00%
-66.7%
Q1 2020$8,001,000
-51.4%
2,614,835
-18.3%
0.00%
-25.0%
Q4 2019$16,459,000
-1.0%
3,202,123
-0.6%
0.00%
-20.0%
Q3 2019$16,625,000
-48.1%
3,221,950
-39.2%
0.01%
-44.4%
Q2 2019$32,049,000
+55.0%
5,297,360
+85.3%
0.01%
+50.0%
Q1 2019$20,674,000
+5.2%
2,859,483
+7.7%
0.01%0.0%
Q4 2018$19,649,000
+1554.0%
2,655,255
+1109.4%
0.01%
Q3 2018$1,188,000
+109.9%
219,552
+37.8%
0.00%
Q2 2018$566,000
+15.5%
159,318
-33.3%
0.00%
Q1 2018$490,000
+21.9%
238,800
+56.7%
0.00%
Q4 2017$402,000
-44.9%
152,407
+9.7%
0.00%
Q3 2017$729,000
+36.5%
138,976
-7.4%
0.00%
Q2 2017$534,000
-14.6%
150,055
+24.2%
0.00%
Q1 2017$625,000
-31.7%
120,863
-49.8%
0.00%
Q4 2016$915,000
-64.1%
240,909
-15.3%
0.00%
-100.0%
Q3 2016$2,548,000
+253.9%
284,385
+177.7%
0.00%
Q2 2016$720,000
-49.7%
102,392
-39.2%
0.00%
Q1 2016$1,430,000
-67.0%
168,287
-49.0%
0.00%
-100.0%
Q4 2015$4,330,000
+1895.4%
329,756
+457.4%
0.00%
Q3 2015$217,000
-56.0%
59,156
-30.9%
0.00%
Q2 2015$493,000
+17.7%
85,585
+19.3%
0.00%
Q1 2015$419,000
+17.0%
71,721
+57.2%
0.00%
Q4 2014$358,000
-81.0%
45,630
-88.1%
0.00%
-100.0%
Q3 2014$1,883,000
+389.1%
383,513
+515.5%
0.00%
Q2 2014$385,000
+134.8%
62,311
+103.2%
0.00%
Q1 2014$164,000
+156.2%
30,662
+151.8%
0.00%
Q4 2013$64,000
+4.9%
12,179
+11.0%
0.00%
Q3 2013$61,000
+144.0%
10,972
-24.6%
0.00%
Q4 2012$25,000
-7.4%
14,546
-1.0%
0.00%
Q3 2012$27,000
-22.9%
14,694
-9.0%
0.00%
Q2 2012$35,000
-39.7%
16,143
-4.7%
0.00%
Q1 2012$58,00016,9470.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q2 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,398,861$31,097,0003.12%
ORACLE INVESTMENT MANAGEMENT INC 3,241,761$18,673,0002.27%
BOURNE LENT ASSET MANAGEMENT INC 152,575$879,0000.69%
Trellus Management Company, LLC 95,800$552,0000.62%
MAVERICK CAPITAL LTD 7,061,034$40,672,0000.62%
Iguana Healthcare Management, LLC 275,000$1,584,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,485,861$8,559,0000.28%
Spark Investment Management LLC 159,400$916,0000.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 147,052$847,0000.13%
EverPoint Asset Management, LLC 900,010$5,184,0000.10%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders